Subcutaneous implantable cardioverter-defibrillator (ICD) for patients at risk of sudden cardiac death

Mundy L, Hiller JE
Record ID 32011000620
Authors' recommendations: Preliminary results indicate that the S-ICD has the potential to detect and eliminate episodes of ventricular tachycardia, however data are required to assess the long-term benefits of S-ICD implantation. Long-term data are also required to be able to assess the stability of leads in comparison to conventional transvenous ICDs. A number of post-implantation complications were noted, including over-sensing and lead dislodgement, and although these complications were rectified, patients needed to undergo revision procedures. In addition, the S-ICD cannot provide long-term pacing and is therefore not an alternative to transvenous ICDs when antibradycardia pacing is required.Preliminary results of this device appear promising and it would be prudent to await the results from the large clinical trial currently being conducted. Therefore HealthPACT have recommended that this technology be monitored for further information in 24 months.
Project Status: Completed
Year Published: 2010
URL for published report: Not Available
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Death, Sudden, Cardiac
Organisation Name: Adelaide Health Technology Assessment
Contact Address: School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
Contact Email:
Copyright: Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.